| IPI00853225 - INS, INSULIN. | |
|---|---|
| Uniprot Accession: A6XGL2 | |
| Uniprot ID: A6XGL2_HUMAN | |
| Mapping: Chr 11, 2137585 - 2139147 | |
| Entrez Gene: 3630 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_1364) |
|---|
| Rat: Ins2, INSULIN-2 PRECURSOR. |
| Mouse: Ins2, INSULIN-2 PRECURSOR. |
| Mouse: Ins2, 9 KDA PROTEIN. |
| Mouse: Ins2, 13 KDA PROTEIN. |
| Human: INS, INSULIN PRECURSOR. |
| Human: INS, INSULIN. |
| Human: INS, 11 KDA PROTEIN. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| extracellular region | C | IC IEA | IEA | IEA |
| secretory granule | C | IDA | IDA IEA | |
| extracellular space | C | RCA | ISS | |
| cellular_component | C | ND | ||
| small nucleolar ribonucleoprotein complex | C | IDA | ISS IEA | |
| nucleus | C | IDA | ISS IEA | |
| soluble fraction | C | IDA | ||
| protein binding | F | IPI | ||
| molecular_function | F | ND | ||
| insulin-like growth factor binding | F | IPI | ||
| insulin receptor binding | F | IDA | ||
| hormone activity | F | NAS IEA | TAS | ISS IEA |
| protease binding | F | IPI | ||
| alpha-beta T cell activation | P | IDA | ||
| positive regulation of vasodilation | P | NAS | ||
| cell death | P | NAS | ||
| lipid catabolic process | P | IDA | ISS IEA | |
| ER overload response | P | IMP | ISS IEA | |
| regulation of apoptosis | P | IMP | ISS IEA | |
| carbohydrate metabolic process | P | IEA | IEA | IEA |
| cell surface receptor linked signal transduction | P | TAS | ||
| activation of MAPK activity | P | IDA | ISS IEA | |
| generation of precursor metabolites and energy | P | TAS | ||
| regulation of phosphorylation | P | IDA | ISS IEA | |
| glucose metabolic process | P | TAS | IMP | ISS IEA |
| positive regulation of nitric-oxide synthase activity | P | NAS | ||
| cell-cell signaling | P | IC | ||
| negative regulation of protein catabolic process | P | IDA | ||
| activation of JNK activity | P | IDA | ||
| positive regulation of cytokine secretion | P | IDA | ||
| regulation of protein secretion | P | IDA | ||
| negative regulation of vasodilation | P | NAS | ||
| positive regulation of nitric oxide biosynthetic process | P | NAS | ||
| acute-phase response | P | NAS | ||
| glucose transport | P | IDA IDA | TAS | ISS |
| regulation of glucose-6-phosphatase activity | P | IDA | ||
| insulin receptor signaling pathway | P | IDA | ISS IEA | |
| biological_process | P | ND |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| skin/coat/nails phenotype | MP | Un | ||
| cellular phenotype | MP | Un Un | ||
| adipose tissue phenotype | MP | Un | ||
| behavior/neurological phenotype | MP | Un | ||
| endocrine/exocrine gland phenotype | MP | Un Un Un Un | ||
| homeostasis/metabolism phenotype | MP | Un Un Un Un | ||
| embryogenesis phenotype | MP | Un | ||
| immune system phenotype | MP | Un Un Un | ||
| skeleton phenotype | MP | Un | ||
| lethality-postnatal | MP | Un Un Un | ||
| renal/urinary system phenotype | MP | Un Un Un Un | ||
| nervous system phenotype | MP | Un | ||
| vision/eye phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un Un Un Un | ||
| hematopoietic system phenotype | MP | Un | ||
| reproductive system phenotype | MP | Un | ||
| liver/biliary system phenotype | MP | Un Un | ||
| growth/size phenotype | MP | Un Un Un Un | ||
| life span-post-weaning/aging | MP | Un Un |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Obesity | D | ISS | ||
| Diabetes Mellitus, Non-Insulin-Dependent | D | ISS | ||
| Hyperinsulinism | D | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Parkinson disease pathway | W | IEA | ||
| dentatorubral-pallidoluysian atrophy disease pathway | W | IEA | ||
| insulin signaling pathway | W | ISS | ||
| Alzheimer disease pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Regulation of autophagy (04140) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| mTOR signaling pathway (04150) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Type II diabetes mellitus (04930) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Regulation of actin cytoskeleton (04810) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Type I diabetes mellitus (04940) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Dentatorubropallidoluysian atrophy (DRPLA) (05050) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Insulin signaling pathway (04910) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Maturity onset diabetes of the young (04950) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |